These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38570586)

  • 41. CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.
    Salaverria I; Royo C; Carvajal-Cuenca A; Clot G; Navarro A; Valera A; Song JY; Woroniecka R; Rymkiewicz G; Klapper W; Hartmann EM; Sujobert P; Wlodarska I; Ferry JA; Gaulard P; Ott G; Rosenwald A; Lopez-Guillermo A; Quintanilla-Martinez L; Harris NL; Jaffe ES; Siebert R; Campo E; Beà S
    Blood; 2013 Feb; 121(8):1394-402. PubMed ID: 23255553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas.
    Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W
    Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
    Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
    Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma.
    Jatiani SS; Christie S; Leshchenko VV; Jain R; Kapoor A; Bisignano P; Lee C; Kaniskan HÜ; Edwards D; Meng F; Laganà A; Youssef Y; Wiestner A; Alinari L; Jin J; Filizola M; Aggarwal AK; Parekh S
    Clin Cancer Res; 2021 Aug; 27(16):4652-4663. PubMed ID: 34158358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Highly sensitive and specific
    Federmann B; Frauenfeld L; Pertsch H; Borgmann V; Steinhilber J; Bonzheim I; Fend F; Quintanilla-Martinez L
    Haematologica; 2020 Mar; 105(3):754-764. PubMed ID: 31296581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prognostic significance of miRNA-223 targeting SOX11 in mantle cell lymphoma].
    Zhang Q; Zhang WT; Wu SS; Yuan JJ; Tian L; Liu YY; Zuo WL; Song YP; Zhou KS
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):579-583. PubMed ID: 30122018
    [No Abstract]   [Full Text] [Related]  

  • 47. SOX11 expression as a MRD molecular marker for MCL in comparison with t(11;14) and IGH rearrangement.
    Szostakowska M; Szymczyk M; Badowska K; Tudek B; Fabisiewicz A
    Med Oncol; 2018 Mar; 35(4):49. PubMed ID: 29520657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated SOX11 mRNA level correlates with favorable prognosis in mantle cell lymphoma.
    He J; Xi Y; Gao N; Xu E; Xie L; Chang J; Liu J
    J BUON; 2019; 24(4):1679-1685. PubMed ID: 31646825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.
    Fernàndez V; Salamero O; Espinet B; Solé F; Royo C; Navarro A; Camacho F; Beà S; Hartmann E; Amador V; Hernández L; Agostinelli C; Sargent RL; Rozman M; Aymerich M; Colomer D; Villamor N; Swerdlow SH; Pileri SA; Bosch F; Piris MA; Montserrat E; Ott G; Rosenwald A; López-Guillermo A; Jares P; Serrano S; Campo E
    Cancer Res; 2010 Feb; 70(4):1408-18. PubMed ID: 20124476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic accuracy of SOX11 immunohistochemistry in mantle cell lymphoma: A meta-analysis.
    Lee W; Shin E; Kim BH; Kim H
    PLoS One; 2019; 14(11):e0225096. PubMed ID: 31714947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.
    Ek S; Dictor M; Jerkeman M; Jirström K; Borrebaeck CA
    Blood; 2008 Jan; 111(2):800-5. PubMed ID: 17934069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SOX11 as a minimal residual disease marker for Mantle cell lymphoma.
    Simonsen AT; Sørensen CD; Ebbesen LH; Bødker JS; Bentzen HH; Nyvold CG
    Leuk Res; 2014 Aug; 38(8):918-24. PubMed ID: 24878000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma.
    Nygren L; Baumgartner Wennerholm S; Klimkowska M; Christensson B; Kimby E; Sander B
    Blood; 2012 May; 119(18):4215-23. PubMed ID: 22431568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. USP9X Increased Tumor Angiogenesis in Mantle Cell Lymphoma by Upregulation of CCND1-Mediated SOX11.
    Huang G; Liao J; Wang M; Huang Y; Tang M; Hao Y
    Mediterr J Hematol Infect Dis; 2022; 14(1):e2022048. PubMed ID: 35865393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Expression of myocyte enhancer factor 2B in mantle cell lymphoma and its clinical significance].
    Liu F; Liu Q; Guo N; Zhang GM; Deng YF; Hu WW; Rao HL
    Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):40-46. PubMed ID: 31914533
    [No Abstract]   [Full Text] [Related]  

  • 56. Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms.
    Chen YH; Gao J; Fan G; Peterson LC
    Mod Pathol; 2010 Jan; 23(1):105-12. PubMed ID: 19801969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients.
    Righi S; Pileri S; Agostinelli C; Bacci F; Spagnolo S; Sabattini E
    Hum Pathol; 2017 Jan; 59():94-101. PubMed ID: 27720733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reactive oxygen species mediate cancer stem-like cells and determine bortezomib sensitivity via Mcl-1 and Zeb-1 in mantle cell lymphoma.
    Luanpitpong S; Poohadsuan J; Samart P; Kiratipaiboon C; Rojanasakul Y; Issaragrisil S
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3739-3753. PubMed ID: 30251692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in bladder cancer.
    Li P; Wang W; Zhu B; Wang Y; Li J; Wang C; Wang C; Li Q
    Environ Toxicol; 2024 May; 39(5):2869-2880. PubMed ID: 38294069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.
    Isaac KM; Portell CA; Williams ME
    Curr Oncol Rep; 2021 Jul; 23(9):102. PubMed ID: 34269910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.